Patents by Inventor Kenton L. Crowley

Kenton L. Crowley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10525093
    Abstract: A composition comprising cannabis extract and melatonin is provided, along with formulations for delivering the composition to a subject. The composition can include a base ingredient such as polyethylene glycol, gelatin, tapioca and/or pectin; natural sweeteners; and oils of peppermint, lavender, ginger, citrus, mango, etc. The formulation can include tablets, capsules, lozenges, troches, suppositories, tinctures, a transdermal patch, a vaporizer, a metered dose inhaler, etc. The formulation avoids harmful preservatives (e.g., BHT, BHA), heavy metals and stabilizers while addressing sub-therapeutic dosing and optimizing the synergistic qualities of the ratios of the individual cannabinoids (both acidic and neutral forms), terpenes and flavonoids.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: January 7, 2020
    Assignee: FARM TO FARMA, INC.
    Inventor: Kenton L. Crowley
  • Patent number: 10420809
    Abstract: A cannabinoid troche including polyethylene glycol (or other base ingredients such as gelatin and/or pectin) and oils of peppermint, ginger, citrus, mango, etc., that is administered buccally and/or sublingually. This dosage form demonstrates an improved efficacy with reduced side effects when compared to formulations of cannabinoids in capsules, oral solutions, tinctures, sprays and edibles. The troches avoid harmful preservatives (e.g., BHT, BHA), heavy metals and stabilizers while addressing sub-therapeutic dosing and optimizing the synergistic qualities of the ratios of the individual cannabinoids, terpenes and flavonoids. The use of peppermint oil (and others) in the troche shows improved efficacy above and beyond that which is expected or seen without its use. The troches further allow for accurate and reproducible therapeutic effects with ease of dosage adjustments.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: September 24, 2019
    Assignee: Farm to Farma, Inc.
    Inventor: Kenton L. Crowley
  • Publication number: 20180133272
    Abstract: A composition comprising cannabis extract and melatonin is provided, along with formulations for delivering the composition to a subject. The composition can include a base ingredient such as polyethylene glycol, gelatin, tapioca and/or pectin; natural sweeteners; and oils of peppermint, lavender, ginger, citrus, mango, etc. The formulation can include tablets, capsules, lozenges, troches, suppositories, tinctures, a transdermal patch, a vaporizer, a metered dose inhaler, etc. The formulation avoids harmful preservatives (e.g., BHT, BHA), heavy metals and stabilizers while addressing sub-therapeutic dosing and optimizing the synergistic qualities of the ratios of the individual cannabinoids (both acidic and neutral forms), terpenes and flavonoids.
    Type: Application
    Filed: November 14, 2017
    Publication date: May 17, 2018
    Inventor: Kenton L. Crowley
  • Publication number: 20170274030
    Abstract: A cannabinoid troche including polyethylene glycol (or other base ingredients such as gelatin and/or pectin) and oils of peppermint, ginger, citrus, mango, etc., that is administered buccally and/or sublingually. This dosage form demonstrates an improved efficacy with reduced side effects when compared to formulations of cannabinoids in capsules, oral solutions, tinctures, sprays and edibles. The troches avoid harmful preservatives (e.g., BHT, BHA), heavy metals and stabilizers while addressing sub-therapeutic dosing and optimizing the synergistic qualities of the ratios of the individual cannabinoids, terpenes and flavonoids. The use of peppermint oil (and others) in the troche shows improved efficacy above and beyond that which is expected or seen without its use. The troches further allow for accurate and reproducible therapeutic effects with ease of dosage adjustments.
    Type: Application
    Filed: April 6, 2017
    Publication date: September 28, 2017
    Applicant: FARM TO FRAMA, INC.
    Inventor: Kenton L. Crowley
  • Patent number: 5817699
    Abstract: The present invention relates to a process for producing a ketamine ointment that is self-administered topically by a subject to alleviate neuropathic, sympathetic medicated pain and myofacial pain said subject is experiencing. The present invention is also utilized to improve the motor skills, alertness, sleeping habits, energy level and overall well-being of a subject suffering from Parkinson's disease.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: October 6, 1998
    Inventors: John A. Flores, Kenton L. Crowley